Seroquel Case: Must AstraZeneca Tell All?

In more lawsuits, companies are being forced to reveal internal information during the pretrial discovery phase that otherwise would be kept private

A showdown is looming in a Florida courtroom over an issue that has long bedeviled business: How much internal information can a company be forced to make public simply because it has become a defendant in a lawsuit?

To continue reading this article you must be a Bloomberg Professional Service Subscriber.